Showing results (231-240 of 283) with videos related to
Sort By:
Pageof 29
The Journal of Clinical Investigation|March 13, 2020
Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfectionXiaoming Cheng, Takuro Uchida, Yuchen Xia, et al.Medicine|June 30, 2021
Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patientsEisuke Murakami, Takashi Nakahara, Akira Hiramatsu, et al.Cellular and Molecular Gastroenterology and Hepatology|February 18, 2017
Circulating Tumor DNA Analysis for Liver Cancers and Its Usefulness as a Liquid BiopsyAtsushi Ono, Akihiro Fujimoto, Yujiro Yamamoto, et al.Cancers|August 27, 2021
Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World PracticeYuwa Ando, Tomokazu Kawaoka, Masanari Kosaka, et al.Hepatology Communications|March 13, 2019
Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver CirrhosisAkira Hiramatsu, Hiroshi Aikata, Shinsuke Uchikawa, et al.Journal of Gastroenterology|March 9, 2019
Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in JapanKoichi Takaguchi, Hidenori Toyoda, Akemi Tsutsui, et al.Therapeutic Advances in Medical Oncology|June 18, 2020
Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinibAtsushi Ono, Hiroshi Aikata, Masami Yamauchi, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 5, 2013
Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseasesKeiichi Masaki, Shintaro Takaki, Hideyuki Hyogo, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 27, 2016
Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis CKei Morio, Michio Imamura, Yoshiiku Kawakami, et al.Journal of Viral Hepatitis|July 13, 2018
CTL-associated and NK cell-associated immune responses induce different HBV DNA reduction patterns in chronic hepatitis B patientsMotonobu Nomura, Masataka Tsuge, Takuro Uchida, et al.Pageof 29